Moreover, IGF-1 is crucial for the maintenance of cochlear synapses [80,81], and it has been approved for the treatment of human sudden sensorineural hearing loss refractory to corticosteroid treatment [82]. Here, IGF1 is linked to sudden sensorineural hearing loss.